Harford Simon N.R. 4
4 · AMICUS THERAPEUTICS, INC. · Filed Aug 23, 2023
Insider Transaction Report
Form 4
Harford Simon N.R.
Chief Financial Officer
Transactions
- Award
Stock Options (right to buy)
2023-08-21+189,043→ 189,043 totalExercise: $12.62Exp: 2033-08-21→ Common Stock (189,043 underlying) - Award
Common Stock
2023-08-21+106,973→ 106,973 total
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on August 21, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.